Researchers in Queensland are exploring the potential of abalone, a luxury seafood, to treat ulcerative colitis, a chronic gut condition that affects numerous Australians. This disease, which falls under the category of inflammatory bowel disease (IBD), occurs when the immune system mistakenly attacks healthy bowel cells, resulting in pain, fatigue, and digestive problems.
Australia has one of the highest rates of IBD globally, with over 100,000 individuals diagnosed. Traditionally, the condition is managed with medication; however, scientists at the Translational Research Institute in Brisbane are investigating a more natural alternative derived from abalone. Jakob Begun, a researcher at the institute, noted that initial findings indicate a whole extract from the abalone exhibits anti-inflammatory effects.
Early experiments conducted on mice show that this extract is about 50% effective in reducing inflammation, a result comparable to some conventional treatments currently available. This development brings hope to many, including 60-year-old Paul McLachlan, whose life was significantly disrupted by his ulcerative colitis diagnosis. He described the debilitating impact of the disease, which once left him avoiding food and consuming excessive amounts of medication like Gastrostop just to manage his symptoms.
Though McLachlan is now in remission due to drug treatments, these often accompany adverse side effects. He expresses a keen interest in new, less invasive treatments, especially those that are more natural. The research team is also investigating the use of abalone off-cuts, which have been found to possess anti-inflammatory properties. This innovative approach seeks to turn food waste from a $250 million industry into therapeutic options, potentially benefiting patients while also being environmentally responsible.
Overall, the Queensland researchers’ efforts could pave the way for new treatments that improve the quality of life for those living with inflammatory bowel diseases like ulcerative colitis.